Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin (Q58903532)
Jump to navigation
Jump to search
scientific article published on 10 December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin |
scientific article published on 10 December 2011 |
Statements
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin (English)
Ombretta Viapiana
Elena Fracassi
10 December 2011